EBD GmbH is part of the Knowledge & Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Biotech Showcase 2015 EBD Group Demy-Colton
Share/Follow Us
Share this:
Follow this event:

Biotech Showcase™ 2016 Press Releases

News for Biotech Showcase™ 2016 will be available soon.

January 27, 2015Biotech Showcase™ 2015 surpasses all previous investor attendance, partnering numbers The seventh annual Biotech Showcase investor conference wrapped up the week of January 12 in San Francisco with the highest number of delegates in attendance since its founding. More than 2,100 executive-level delegates representing qualified private and public equity investors, industry analysts, bankers, pharmaceutical and biotechnology industry executives attended from...  more ►

January 2, 2015Biotech Showcase™ 2015 kicks off in one week
Over 2,000 life science executive dealmakers expected to attend
The seventh annual Biotech Showcase investor conference takes place in just over one week on January 12–14, 2015 in San Francisco, CA at Parc 55 Wyndham San Francisco - Union Square. Biotech Showcase is an investor conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and ph...  more ►

November 18, 2014Seventh Annual Biotech Showcase™ to be held in San Francisco January 12–14, 2015-- Record number of Life Science Investor meetings expected
The seventh annual Biotech Showcase investor conference will be held January 12–14, 2015 in San Francisco, CA at Parc 55 Wyndham San Francisco - Union Square. The event brings executive-level delegates representing top public and private investment firms with the goal to meet management teams of biotechnology and life science companies, including therapeutic companies, sp...  more ►

partnering360:Insight Latest headlines from partnering360:Insight

October 12, 2015 Serodus advances novel cardiovascular and metabolic treatments to out-licensing Five compounds in the pipeline in just five years since Professor Eva Steiness became CEO, two already in Phase II trials. And having established a stable financial base, thanks to a listing on the Oslo Axess stock exchange, Serodus is now entering a partnering mode, according to Dr. Jürgen Langhärig, VP for Business Development. He arrives at BIO-Europe in Munich with a sharp focus on initiating out-licensing discussions. more ►

October 9, 2015 Quintiles: Expanding options for emerging companies Executives at small, or emerging, biopharmaceutical companies often think their only viable options are to out-license products to larger players or to be acquired. Quintiles, a leading biopharmaceutical services provider, says there is an alternative. Working with a full-service provider can provide specific expertise on-demand, without adding staff to the payroll. more ►

October 7, 2015 MSD: Opportunities in animal and human collaborations Collaborating with animal health drug developers isn't a common developmental strategy for human pharmaceutical development, but it offers benefits worth considering—for both parties. Working at the intersection of human and animal health can potentially shorten time to commercialization by improving the understanding of the underlying science and by providing early notice of potential issues. more ►

September 22, 2015 Shanghai CPGJ Pharma steps up to partnering at BIO-Europe 2015 Introducing itself for the first time at BIO-Europe 2015 in Munich, Shanghai CPGJ uniquely holds the largest monoclonal antibody production capacity in China and has been awarded four national high-tech industrialization enterprises. Shanghai CP GuoJian Pharmaceutical Company looks forward to meeting potential partners for strategic alliances in target markets. more ►

August 29, 2015 HSCI fosters broad collaboration At the Harvard Stem Cell Institute (HSCI), "Partnering is important at all levels," emphasized Brock Reeve, executive director. That impetus is important not just in the sciences, but also among foundations, large and small companies and investors throughout the life sciences community. more ►

Arrow Up

Follow this event:
Sign up now
For news and updates

Privacy Policy and Cookies Terms of Use

Home | Contact Us | Site Map
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2015 EBD Group, Inc.
Privacy Policy and Cookies
Terms of Use